NCT00321139View on ClinicalTrials.gov

Assessment of Translesional Markers and Metabolomics

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

January 31, 2007

Conditions
Coronary Artery Disease
Trial Locations (1)

30322

Emory University Hospital, Atlanta

Sponsors
All Listed Sponsors
collaborator

Boston Scientific Corporation

INDUSTRY

lead

Emory University

OTHER

NCT00321139 - Assessment of Translesional Markers and Metabolomics | Biotech Hunter | Biotech Hunter